Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Imaging, Cine | 47 | 2024 | 1091 | 12.590 |
Why?
|
Image Interpretation, Computer-Assisted | 54 | 2024 | 3390 | 8.110 |
Why?
|
Myocardium | 46 | 2024 | 4788 | 7.210 |
Why?
|
Heart | 43 | 2024 | 4446 | 6.590 |
Why?
|
Gadolinium | 21 | 2024 | 964 | 5.470 |
Why?
|
Magnetic Resonance Imaging | 84 | 2024 | 36743 | 4.740 |
Why?
|
Image Enhancement | 40 | 2021 | 2880 | 4.720 |
Why?
|
Cardiomyopathy, Hypertrophic | 13 | 2024 | 1334 | 4.240 |
Why?
|
Respiratory-Gated Imaging Techniques | 11 | 2022 | 75 | 3.700 |
Why?
|
Cicatrix | 19 | 2023 | 798 | 3.520 |
Why?
|
Imaging, Three-Dimensional | 35 | 2020 | 4063 | 3.510 |
Why?
|
Contrast Media | 32 | 2024 | 5330 | 3.430 |
Why?
|
Magnetic Resonance Angiography | 18 | 2014 | 1429 | 3.420 |
Why?
|
Cardiac-Gated Imaging Techniques | 11 | 2015 | 139 | 3.180 |
Why?
|
Artifacts | 20 | 2021 | 1926 | 3.090 |
Why?
|
Meglumine | 8 | 2019 | 144 | 2.540 |
Why?
|
Organometallic Compounds | 9 | 2019 | 648 | 2.490 |
Why?
|
Ventricular Function, Left | 20 | 2024 | 3941 | 2.440 |
Why?
|
Coronary Vessels | 18 | 2015 | 3124 | 2.330 |
Why?
|
Heart Ventricles | 15 | 2024 | 3841 | 2.290 |
Why?
|
Cardiomyopathy, Dilated | 5 | 2024 | 843 | 2.220 |
Why?
|
Cardiac Imaging Techniques | 5 | 2018 | 280 | 2.180 |
Why?
|
Predictive Value of Tests | 39 | 2024 | 15454 | 2.090 |
Why?
|
Phantoms, Imaging | 25 | 2023 | 2512 | 2.080 |
Why?
|
Reproducibility of Results | 55 | 2024 | 20227 | 1.880 |
Why?
|
Signal Processing, Computer-Assisted | 9 | 2018 | 1489 | 1.860 |
Why?
|
Algorithms | 37 | 2024 | 14164 | 1.850 |
Why?
|
Blood Flow Velocity | 7 | 2021 | 1375 | 1.840 |
Why?
|
Image Processing, Computer-Assisted | 20 | 2024 | 9015 | 1.720 |
Why?
|
Tachycardia, Ventricular | 9 | 2020 | 1309 | 1.700 |
Why?
|
Pulmonary Veins | 7 | 2015 | 758 | 1.640 |
Why?
|
Respiratory Mechanics | 8 | 2015 | 721 | 1.540 |
Why?
|
Stroke Volume | 12 | 2024 | 5622 | 1.510 |
Why?
|
Respiration | 9 | 2021 | 1665 | 1.400 |
Why?
|
Defibrillators, Implantable | 7 | 2024 | 1498 | 1.360 |
Why?
|
Cardiomyopathies | 8 | 2024 | 2056 | 1.330 |
Why?
|
Heart Atria | 6 | 2018 | 1361 | 1.320 |
Why?
|
Data Compression | 3 | 2014 | 69 | 1.240 |
Why?
|
Fibrosis | 14 | 2024 | 2080 | 1.220 |
Why?
|
Heart Diseases | 7 | 2024 | 2819 | 1.210 |
Why?
|
Myocardial Infarction | 13 | 2019 | 11519 | 1.170 |
Why?
|
Heart Rate | 9 | 2022 | 4214 | 1.110 |
Why?
|
Catheter Ablation | 10 | 2020 | 2780 | 0.960 |
Why?
|
Doxorubicin | 2 | 2024 | 2234 | 0.960 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2024 | 2145 | 0.950 |
Why?
|
Sensitivity and Specificity | 31 | 2020 | 14729 | 0.940 |
Why?
|
Papillary Muscles | 3 | 2016 | 192 | 0.920 |
Why?
|
Arrhythmias, Cardiac | 6 | 2024 | 2258 | 0.920 |
Why?
|
Atrial Fibrillation | 10 | 2018 | 5176 | 0.920 |
Why?
|
Ventricular Remodeling | 7 | 2020 | 1281 | 0.910 |
Why?
|
Male | 100 | 2024 | 364719 | 0.850 |
Why?
|
Coronary Circulation | 6 | 2019 | 1617 | 0.820 |
Why?
|
Endomyocardial Fibrosis | 2 | 2020 | 41 | 0.810 |
Why?
|
Gadolinium DTPA | 6 | 2013 | 823 | 0.810 |
Why?
|
Models, Cardiovascular | 4 | 2019 | 981 | 0.810 |
Why?
|
Humans | 143 | 2024 | 768166 | 0.790 |
Why?
|
Swine, Miniature | 2 | 2024 | 965 | 0.790 |
Why?
|
Heart Conduction System | 2 | 2019 | 1009 | 0.780 |
Why?
|
Middle Aged | 68 | 2024 | 223492 | 0.780 |
Why?
|
Motion | 11 | 2018 | 790 | 0.780 |
Why?
|
Exercise Test | 3 | 2022 | 2186 | 0.750 |
Why?
|
Female | 93 | 2024 | 397192 | 0.750 |
Why?
|
Adult | 68 | 2024 | 223646 | 0.740 |
Why?
|
Atrial Function, Left | 2 | 2018 | 188 | 0.700 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2021 | 672 | 0.690 |
Why?
|
Myocardial Contraction | 4 | 2020 | 1525 | 0.680 |
Why?
|
Magnetic Resonance Spectroscopy | 8 | 2024 | 3780 | 0.680 |
Why?
|
Electrocardiography | 11 | 2022 | 6412 | 0.630 |
Why?
|
Swine | 14 | 2024 | 5995 | 0.610 |
Why?
|
Electrophysiologic Techniques, Cardiac | 6 | 2020 | 511 | 0.610 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2019 | 153 | 0.600 |
Why?
|
Coronary Artery Disease | 6 | 2022 | 6568 | 0.600 |
Why?
|
Holography | 1 | 2018 | 80 | 0.590 |
Why?
|
Prospective Studies | 22 | 2024 | 54926 | 0.580 |
Why?
|
Movement | 5 | 2018 | 1490 | 0.580 |
Why?
|
Pulmonary Artery | 2 | 2018 | 1946 | 0.560 |
Why?
|
Body Surface Potential Mapping | 3 | 2017 | 228 | 0.550 |
Why?
|
Retrospective Studies | 26 | 2024 | 81762 | 0.550 |
Why?
|
Pattern Recognition, Automated | 2 | 2014 | 993 | 0.540 |
Why?
|
Adipose Tissue | 3 | 2024 | 3329 | 0.530 |
Why?
|
Aged | 39 | 2024 | 171504 | 0.530 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1738 | 0.530 |
Why?
|
Tachycardia, Paroxysmal | 1 | 2015 | 30 | 0.520 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2022 | 646 | 0.510 |
Why?
|
Aorta | 4 | 2014 | 2045 | 0.490 |
Why?
|
Angina Pectoris | 1 | 2019 | 957 | 0.490 |
Why?
|
Mitral Valve Prolapse | 3 | 2016 | 213 | 0.490 |
Why?
|
Veins | 2 | 2010 | 769 | 0.480 |
Why?
|
Subtraction Technique | 2 | 2015 | 517 | 0.470 |
Why?
|
Sarcoidosis | 1 | 2020 | 535 | 0.470 |
Why?
|
Blood | 1 | 2017 | 599 | 0.460 |
Why?
|
Sus scrofa | 4 | 2019 | 430 | 0.460 |
Why?
|
Myocardial Stunning | 1 | 2014 | 67 | 0.450 |
Why?
|
Acceleration | 1 | 2014 | 189 | 0.440 |
Why?
|
Coronary Angiography | 7 | 2019 | 4541 | 0.440 |
Why?
|
Primary Prevention | 3 | 2024 | 1188 | 0.440 |
Why?
|
Radio Waves | 2 | 2012 | 250 | 0.440 |
Why?
|
Hyperventilation | 1 | 2013 | 78 | 0.440 |
Why?
|
Phlebography | 1 | 2014 | 326 | 0.430 |
Why?
|
Pericardium | 1 | 2018 | 679 | 0.430 |
Why?
|
Respiratory Rate | 1 | 2014 | 180 | 0.430 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2019 | 856 | 0.430 |
Why?
|
Disease Models, Animal | 10 | 2024 | 18349 | 0.430 |
Why?
|
Feasibility Studies | 7 | 2022 | 5315 | 0.430 |
Why?
|
Magnetics | 2 | 2018 | 597 | 0.420 |
Why?
|
Computer Simulation | 8 | 2018 | 6283 | 0.410 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2665 | 0.410 |
Why?
|
Death, Sudden, Cardiac | 4 | 2023 | 1567 | 0.400 |
Why?
|
Myocarditis | 1 | 2020 | 802 | 0.400 |
Why?
|
Electrodiagnosis | 1 | 2012 | 149 | 0.390 |
Why?
|
Action Potentials | 1 | 2019 | 1838 | 0.380 |
Why?
|
Wavelet Analysis | 1 | 2011 | 56 | 0.370 |
Why?
|
Young Adult | 18 | 2024 | 60066 | 0.360 |
Why?
|
Echo-Planar Imaging | 1 | 2014 | 648 | 0.350 |
Why?
|
Stilbenes | 4 | 2012 | 155 | 0.350 |
Why?
|
Isosorbide Dinitrate | 1 | 2010 | 34 | 0.340 |
Why?
|
Mitral Valve | 2 | 2016 | 1475 | 0.340 |
Why?
|
Electric Countershock | 1 | 2013 | 534 | 0.340 |
Why?
|
Time Factors | 11 | 2024 | 40218 | 0.340 |
Why?
|
Reference Values | 5 | 2016 | 4938 | 0.330 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 15662 | 0.330 |
Why?
|
Heart Failure | 3 | 2021 | 11879 | 0.320 |
Why?
|
Hypertension | 2 | 2019 | 8616 | 0.320 |
Why?
|
Myocardial Ischemia | 5 | 2013 | 2138 | 0.320 |
Why?
|
Case-Control Studies | 8 | 2024 | 22291 | 0.310 |
Why?
|
Amyloidosis | 1 | 2015 | 878 | 0.290 |
Why?
|
Numerical Analysis, Computer-Assisted | 2 | 2020 | 119 | 0.290 |
Why?
|
Disease Progression | 1 | 2024 | 13671 | 0.280 |
Why?
|
Mitral Valve Insufficiency | 1 | 2016 | 1415 | 0.270 |
Why?
|
Aorta, Thoracic | 1 | 2013 | 1110 | 0.270 |
Why?
|
Supine Position | 2 | 2019 | 208 | 0.270 |
Why?
|
Automation | 2 | 2019 | 589 | 0.260 |
Why?
|
Water | 1 | 2012 | 1421 | 0.260 |
Why?
|
Brain Chemistry | 1 | 2009 | 958 | 0.250 |
Why?
|
Vasodilator Agents | 1 | 2010 | 990 | 0.250 |
Why?
|
Normal Distribution | 2 | 2018 | 272 | 0.240 |
Why?
|
Models, Theoretical | 4 | 2018 | 3573 | 0.230 |
Why?
|
Observer Variation | 4 | 2020 | 2622 | 0.230 |
Why?
|
Pilot Projects | 6 | 2019 | 8741 | 0.210 |
Why?
|
Radiography | 3 | 2024 | 6983 | 0.210 |
Why?
|
Prognosis | 5 | 2024 | 30010 | 0.210 |
Why?
|
Risk Factors | 9 | 2024 | 74944 | 0.200 |
Why?
|
Oxygen | 1 | 2013 | 4270 | 0.190 |
Why?
|
Polyethylene | 1 | 2023 | 187 | 0.190 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.190 |
Why?
|
Echocardiography | 2 | 2021 | 5047 | 0.190 |
Why?
|
Adiposity | 2 | 2024 | 1895 | 0.190 |
Why?
|
Animals | 18 | 2024 | 169246 | 0.190 |
Why?
|
Principal Component Analysis | 1 | 2024 | 948 | 0.180 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2862 | 0.180 |
Why?
|
Adaptation, Biological | 1 | 2001 | 147 | 0.180 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 845 | 0.170 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 681 | 0.170 |
Why?
|
Infarction | 1 | 2020 | 247 | 0.160 |
Why?
|
Epicardial Mapping | 1 | 2018 | 58 | 0.160 |
Why?
|
Hand Strength | 1 | 2001 | 466 | 0.150 |
Why?
|
Arm | 1 | 2001 | 591 | 0.150 |
Why?
|
Motor Skills | 1 | 2001 | 523 | 0.150 |
Why?
|
Tissue Survival | 1 | 2018 | 120 | 0.150 |
Why?
|
Endocardium | 2 | 2017 | 249 | 0.150 |
Why?
|
Obesity | 1 | 2020 | 13090 | 0.150 |
Why?
|
Electrophysiological Phenomena | 1 | 2019 | 309 | 0.140 |
Why?
|
Electrodes | 2 | 2017 | 617 | 0.140 |
Why?
|
Echocardiography, Doppler | 2 | 2019 | 898 | 0.140 |
Why?
|
Risk Assessment | 6 | 2024 | 24315 | 0.140 |
Why?
|
Exercise | 1 | 2013 | 5955 | 0.140 |
Why?
|
Patient Positioning | 1 | 2019 | 332 | 0.130 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2019 | 483 | 0.130 |
Why?
|
Collagen | 1 | 2024 | 2643 | 0.130 |
Why?
|
Microelectrodes | 1 | 2017 | 305 | 0.130 |
Why?
|
Models, Anatomic | 1 | 2019 | 680 | 0.130 |
Why?
|
Aged, 80 and over | 5 | 2019 | 59629 | 0.130 |
Why?
|
Recurrence | 3 | 2018 | 8509 | 0.120 |
Why?
|
Follow-Up Studies | 4 | 2018 | 39348 | 0.120 |
Why?
|
Catheters | 2 | 2020 | 427 | 0.120 |
Why?
|
Time | 1 | 2017 | 552 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 1 | 2019 | 577 | 0.120 |
Why?
|
Treatment Outcome | 7 | 2019 | 65371 | 0.120 |
Why?
|
Ventricular Fibrillation | 1 | 2017 | 537 | 0.120 |
Why?
|
Equipment Design | 2 | 2014 | 3522 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2019 | 709 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1194 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1140 | 0.110 |
Why?
|
Cerebellum | 1 | 2001 | 1522 | 0.110 |
Why?
|
Workflow | 1 | 2019 | 860 | 0.110 |
Why?
|
Linear Models | 2 | 2016 | 5884 | 0.110 |
Why?
|
Postoperative Period | 1 | 2018 | 1826 | 0.110 |
Why?
|
Biopsy | 1 | 2024 | 6793 | 0.100 |
Why?
|
Tomography, X-Ray Computed | 4 | 2009 | 20760 | 0.100 |
Why?
|
Odds Ratio | 1 | 2024 | 9669 | 0.100 |
Why?
|
Diaphragm | 1 | 2013 | 357 | 0.090 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 2725 | 0.090 |
Why?
|
Organ Size | 1 | 2016 | 2267 | 0.090 |
Why?
|
Ventricular Function | 1 | 2012 | 405 | 0.090 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15948 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2014 | 1587 | 0.090 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 367 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3436 | 0.090 |
Why?
|
Administration, Sublingual | 1 | 2010 | 60 | 0.090 |
Why?
|
Systole | 1 | 2012 | 937 | 0.090 |
Why?
|
Diastole | 1 | 2012 | 785 | 0.090 |
Why?
|
Cardiac Output | 1 | 2012 | 838 | 0.090 |
Why?
|
Boston | 2 | 2020 | 9374 | 0.080 |
Why?
|
Aortic Valve | 1 | 2019 | 1970 | 0.080 |
Why?
|
Endoscopy | 1 | 2018 | 1854 | 0.080 |
Why?
|
Adolescent | 4 | 2019 | 89169 | 0.080 |
Why?
|
Coronary Stenosis | 1 | 2014 | 802 | 0.070 |
Why?
|
Prosthesis Failure | 1 | 2013 | 1208 | 0.070 |
Why?
|
Age Factors | 1 | 2024 | 18412 | 0.070 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2006 | 110 | 0.070 |
Why?
|
Neovascularization, Physiologic | 2 | 2010 | 1369 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3986 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2012 | 1407 | 0.070 |
Why?
|
Prosthesis Design | 1 | 2013 | 2125 | 0.060 |
Why?
|
Infusions, Intravenous | 1 | 2010 | 2230 | 0.060 |
Why?
|
Microcirculation | 1 | 2010 | 1281 | 0.060 |
Why?
|
Comorbidity | 1 | 2020 | 10590 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 2 | 2013 | 6526 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1673 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 469 | 0.060 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1145 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13014 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12077 | 0.050 |
Why?
|
Calibration | 1 | 2005 | 819 | 0.050 |
Why?
|
Prevalence | 1 | 2020 | 15869 | 0.050 |
Why?
|
Sepharose | 1 | 2023 | 102 | 0.050 |
Why?
|
Bayes Theorem | 1 | 2011 | 2359 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14783 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6847 | 0.050 |
Why?
|
Brain | 1 | 2009 | 27360 | 0.050 |
Why?
|
Cerebellar Nuclei | 1 | 2001 | 54 | 0.050 |
Why?
|
Child | 2 | 2020 | 80917 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10840 | 0.050 |
Why?
|
Patient Selection | 1 | 2013 | 4260 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12543 | 0.050 |
Why?
|
Cerebellar Cortex | 1 | 2001 | 108 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2271 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2005 | 830 | 0.040 |
Why?
|
Pliability | 1 | 2019 | 58 | 0.040 |
Why?
|
Models, Statistical | 2 | 2011 | 5107 | 0.040 |
Why?
|
Nonlinear Dynamics | 1 | 2001 | 493 | 0.040 |
Why?
|
Consensus | 2 | 2020 | 3212 | 0.040 |
Why?
|
Survival Rate | 1 | 2013 | 12840 | 0.040 |
Why?
|
Software | 1 | 2012 | 4478 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2001 | 1126 | 0.040 |
Why?
|
Chronic Disease | 3 | 2019 | 9384 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2014 | 6669 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 41754 | 0.040 |
Why?
|
Coronary Disease | 2 | 2010 | 5919 | 0.030 |
Why?
|
Functional Laterality | 1 | 2001 | 2264 | 0.030 |
Why?
|
Models, Neurological | 1 | 2001 | 1776 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2007 | 3433 | 0.020 |
Why?
|
Glucose Transporter Type 4 | 1 | 2011 | 241 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3436 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 64 | 0.020 |
Why?
|
Neural Pathways | 1 | 2001 | 3117 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2010 | 224 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 394 | 0.020 |
Why?
|
Collateral Circulation | 1 | 2010 | 291 | 0.020 |
Why?
|
Recovery of Function | 1 | 2019 | 2981 | 0.020 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 1566 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10873 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2474 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1183 | 0.020 |
Why?
|
Capillaries | 1 | 2010 | 755 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 585 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6685 | 0.020 |
Why?
|
Perfusion | 1 | 2010 | 1401 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2000 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 905 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1951 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3968 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2227 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5027 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2661 | 0.010 |
Why?
|
Neurons | 1 | 2001 | 9514 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2914 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3139 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8080 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2056 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2009 | 2735 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4035 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 3514 | 0.010 |
Why?
|
Calcinosis | 1 | 2007 | 1481 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3445 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 2191 | 0.010 |
Why?
|
Insulin | 1 | 2011 | 6607 | 0.010 |
Why?
|
Stents | 1 | 2007 | 3195 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11928 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 9495 | 0.010 |
Why?
|
Diet | 1 | 2011 | 8089 | 0.010 |
Why?
|
Signal Transduction | 1 | 2010 | 23645 | 0.000 |
Why?
|